OA
CL icon

Operose Advisors’s Colgate-Palmolive CL Stock Holding History

Operose Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$341 – 542
2026
Q1 		$341 Buy
+4
New +$357 ﹤0.01% 570
2024
Q4 		– Sell
-124
Closed -$12.9K – 467
2024
Q3 		$12.9K Hold
124
– – ﹤0.01% 460
2024
Q2 		$12K Hold
124
– – ﹤0.01% 422
2024
Q1 		$11.2K Hold
124
– – ﹤0.01% 474
2023
Q4 		$9.88K Sell
124
-191
-61% -$14.4K ﹤0.01% 470
2023
Q3 		$22.4K Buy
+315
New +$23.6K 0.01% 461
2023
Q1 		– Sell
-1,078
Closed -$84.9K – 354
2022
Q4 		$84.9K Buy
1,078
+943
+699% +$70.7K 0.05% 125
2022
Q3 		$9K Sell
135
-460
-77% -$36.1K 0.01% 270
2022
Q2 		$48K Hold
595
– – 0.03% 141
2022
Q1 		$45K Buy
595
+460
+341% +$36.4K 0.03% 157
2021
Q4 		$12K Buy
+135
New +$10.5K 0.01% 246

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Operose Advisors's CL Position: Q2 2026 in Review

Operose Advisors sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 4 shares — an estimated $341 sold.

Operose Advisors first reported a position in CL in Q4 2021 and held it in 11 quarters. The position peaked at $84.9K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Operose Advisors reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Operose Advisors sold 4 Colgate-Palmolive shares in Q2 2026, an estimated $341.
  • Operose Advisors first reported a position in Colgate-Palmolive in Q4 2021 and held it in 11 quarters.
  • Operose Advisors's Colgate-Palmolive position peaked at $84.9K in Q4 2022.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.